Glycosylation: impact, control and improvement during therapeutic protein production
暂无分享,去创建一个
Mariana Henriques | Rosário Oliveira | Maria Elisa Rodrigues | Ana Rita Costa | Joana Azeredo | A. R. Costa | Rosário Oliveira | M. Henriques | J. Azeredo | M. E. Rodrigues
[1] B. Scallon,et al. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality. , 2007, Molecular immunology.
[2] Uwe Kärst,et al. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. , 2003, Biotechnology and bioengineering.
[3] M. Ruffin,et al. An N-glycosylation Analysis of Human Alpha-2-Macroglobulin Using an Integrated Approach. , 2012, Journal of proteomics & bioinformatics.
[4] André M Deelder,et al. IgG glycosylation analysis , 2009, Proteomics.
[5] R. Wagner,et al. Incorporation of ammonium into intracellular UDP-activated N-acetylhexosamines and into carbohydrate structures in glycoproteins. , 1999, Biotechnology and bioengineering.
[6] R. Cummings,et al. Antibodies and Lectins in Glycan Analysis , 2009 .
[7] T. Dingermann. Recombinant therapeutic proteins: Production platforms and challenges , 2008, Biotechnology journal.
[8] Gyun Min Lee,et al. Effect of low culture temperature on specific productivity, transcription level, and heterogeneity of erythropoietin in Chinese hamster ovary cells. , 2003, Biotechnology and bioengineering.
[9] A. Deelder,et al. Protein glycosylation analyzed by normal-phase nano-liquid chromatography--mass spectrometry of glycopeptides. , 2005, Analytical chemistry.
[10] Jean-Luc Teillaud,et al. Impact of Glycosylation on Effector Functions of Therapeutic IgG † , 2010, Pharmaceuticals.
[11] S. Kaveri,et al. A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes , 2007, Proceedings of the National Academy of Sciences.
[12] J. L. Abrahams,et al. Glycosylation of Therapeutic IgGs , 2009 .
[13] Naoko Yamane-Ohnuki,et al. Production of therapeutic antibodies with controlled fucosylation , 2009, mAbs.
[14] Kai Griebenow,et al. Effects of glycosylation on the stability of protein pharmaceuticals. , 2009, Journal of pharmaceutical sciences.
[15] Wei-Shou Hu,et al. Cell culture technology for pharmaceutical and cell-based therapies , 2005 .
[16] Pauline M Rudd,et al. Determining the Structure of Oligosaccharides N‐ and O‐Linked to Glycoproteins , 2000, Current protocols in protein science.
[17] J. Egrie,et al. Development and characterization of novel erythropoiesis stimulating protein (NESP) , 2001, British Journal of Cancer.
[18] MaryAnn Foote,et al. Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge. , 2004, Biotechnology annual review.
[19] A. Wolf,et al. High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G. , 2006, Molecular immunology.
[20] M J Keen,et al. Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. , 1995, Glycobiology.
[21] Pauline M. Rudd,et al. Determining the Structure of Oligosaccharides N‐ and O‐Linked to Glycoproteins , 2000 .
[22] A. Keating,et al. Functional properties and genomics of glucose transporters. , 2007, Current genomics.
[23] Thomas A Kost,et al. Baculovirus as versatile vectors for protein expression in insect and mammalian cells , 2005, Nature Biotechnology.
[24] T. Rademacher,et al. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity. , 1994, Human antibodies and hybridomas.
[25] T Etcheverry,et al. Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: characterization of separation efficiency and impact of perfusion on product quality. , 2000, Biotechnology and bioengineering.
[26] G. N. Rogers,et al. Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system , 2007, Biotechnology and bioengineering.
[27] J. Dennis,et al. The extent of polylactosamine glycosylation of MDCK LAMP-2 is determined by its Golgi residence time. , 1998, Glycobiology.
[28] Nigel Jenkins,et al. Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.
[29] Quynh-Thu Le,et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. , 2008, The New England journal of medicine.
[30] R. Wagner,et al. Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions. , 1995, Journal of biotechnology.
[31] Youwei Jiang,et al. Optimization of humanized IgGs in glycoengineered Pichia pastoris , 2006, Nature Biotechnology.
[32] K. Cantell,et al. Effect of carbohydrates on the pharmacokinetics of human interferon-gamma. , 1993, Journal of interferon research.
[33] Eleftherios T. Papoutsakis,et al. Culture pH Affects Expression Rates and Glycosylation of Recombinant Mouse Placental Lactogen Proteins by Chinese Hamster Ovary (CHO) Cells , 1993, Bio/Technology.
[34] N. Sharon,et al. Protein glycosylation. Structural and functional aspects. , 1993, European journal of biochemistry.
[35] M. Butler,et al. The Effect of Cell Culture Parameters on Protein Glycosylation , 2002 .
[36] Quynh-Thu Le,et al. Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose , 2008 .
[37] M. Butler,et al. Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. , 1998, Journal of biotechnology.
[38] W. C. Wang,et al. The poly-N-acetyllactosamines attached to lysosomal membrane glycoproteins are increased by the prolonged association with the Golgi complex. , 1991, The Journal of biological chemistry.
[39] N J Stark,et al. Glucose-dependent glycosylation of secretory glycoprotein in mouse myeloma cells. , 1979, Archives of biochemistry and biophysics.
[40] C. Silverman,et al. Heavy Chain Dimers as Well as Complete Antibodies Are Efficiently Formed and Secreted from Drosophila via a BiP-mediated Pathway (*) , 1995, The Journal of Biological Chemistry.
[41] M. Taverna,et al. Electrophoretic methods for process monitoring and the quality assessment of recombinant glycoproteins , 1998, Electrophoresis.
[42] J. Geigert. The Challenge of CMC Regulatory Compliance for Biopharmaceuticals , 2003, Springer US.
[43] Jürgen Frank,et al. Serum-free cell culture: the serum-free media interactive online database. , 2010, ALTEX.
[44] Y. Vugmeyster,et al. Rituximab-mediated depletion of cynomolgus monkey B cells in vitro in different matrices: possible inhibitory effect of IgG. , 2004, International immunopharmacology.
[45] S. Levitz,et al. Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. , 2007, Vaccine.
[46] D. Stuart,et al. Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions. , 2009, Journal of molecular biology.
[47] Niki S. C. Wong,et al. Engineering mammalian cells in bioprocessing – current achievements and future perspectives , 2010, Biotechnology and applied biochemistry.
[48] Michael Butler,et al. Animal cell cultures: recent achievements and perspectives in the production of biopharmaceuticals , 2005, Applied Microbiology and Biotechnology.
[49] S. Iida,et al. Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity. , 2007, Molecular immunology.
[50] R. Dwek,et al. Analysis of N‐ and O‐linked glycans of glycoproteins , 2005 .
[51] Ziv Roth,et al. Identification and Quantification of Protein Glycosylation , 2012 .
[52] L. Mahal,et al. A lectin microarray approach for the rapid analysis of bacterial glycans , 2006, Nature Protocols.
[53] T. Butters. Control in the N-linked glycoprotein biosynthesis pathway. , 2002, Chemistry & biology.
[54] F. Altmann,et al. N-Glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans , 2011, Glycobiology.
[55] Danny Chee Furng Wong,et al. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. , 2005, Biotechnology and bioengineering.
[56] M. Butler,et al. Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. , 2000, Biotechnology and bioengineering.
[57] P. Lerouge,et al. Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose. , 2003, Glycobiology.
[58] F. Regnier,et al. Proteomics of glycoproteins based on affinity selection of glycopeptides from tryptic digests. , 2001, Journal of chromatography. B, Biomedical sciences and applications.
[59] D. James,et al. Glycosylation of Recombinant Proteins , 2002 .
[60] Alves,et al. Effects of ammonia and lactate on growth, metabolism, and productivity of BHK cells. , 2000, Enzyme and microbial technology.
[61] W. Hancock,et al. Monitoring of Glycoprotein Products in Cell Culture Lysates Using Lectin Affinity Chromatography and Capillary HPLC Coupled to Electrospray Linear Ion Trap‐Fourier Transform Mass Spectrometry (LTQ/FTMS) , 2006, Biotechnology progress.
[62] R. Jefferis,et al. Butyrate increases production of human chimeric IgG in CHO-K1 cells whilst maintaining function and glycoform profile. , 2001, Journal of immunological methods.
[63] S. Levitz,et al. Effect of Differential N-linked and O-linked Mannosylation on Recognition of Fungal Antigens by Dendritic Cells , 2007, PloS one.
[64] Daniel I. C. Wang,et al. Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine. , 1998, Biotechnology and bioengineering.
[65] D. Covas,et al. Human cells: new platform for recombinant therapeutic protein production. , 2012, Protein expression and purification.
[66] F. Wurm. Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.
[67] S. Iida,et al. Non-fucosylated therapeutic antibodies as next-generation therapeutic antibodies , 2006, Expert opinion on biological therapy.
[68] S. Kornfeld,et al. Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.
[69] A. Schwartz,et al. Receptor-mediated endocytosis. , 1985, The Biochemical journal.
[70] R. Kunert,et al. A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits. , 2007, Glycobiology.
[71] R. Dwek,et al. Analytical and preparative separation of anionic oligosaccharides by weak anion-exchange high-performance liquid chromatography on an inert polymer column. , 1994, Analytical biochemistry.
[72] Christian Gerdes,et al. Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering. , 2005, Cancer research.
[73] P. Højrup,et al. Characterization of Gel-separated Glycoproteins Using Two-step Proteolytic Digestion Combined with Sequential Microcolumns and Mass Spectrometry* , 2005, Molecular & Cellular Proteomics.
[74] K. Shitara,et al. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.
[75] Lara K Mahal,et al. A ratiometric lectin microarray approach to analysis of the dynamic mammalian glycome , 2007, Proceedings of the National Academy of Sciences.
[76] S. Iida,et al. Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa , 2006, Clinical Cancer Research.
[77] N. Callewaert,et al. Engineering of glycosylation in yeast and other fungi: current state and perspectives , 2010, Applied Microbiology and Biotechnology.
[78] D. James,et al. Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro , 2005, Biotechnology progress.
[79] S. Peterman,et al. A novel approach for identification and characterization of glycoproteins using a hybrid linear ion trap/FT-ICR mass spectrometer , 2006, Journal of the American Society for Mass Spectrometry.
[80] C. Goochee,et al. The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. , 1994, Current opinion in biotechnology.
[81] J. Sambrook,et al. Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylation. , 1992, The Biochemical journal.
[82] L. Presta,et al. Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.
[83] M Goodall,et al. Control of IgG/Fc glycosylation: a comparison of oligosaccharides from chimeric human/mouse and mouse subclass immunoglobulin Gs. , 1993, Molecular immunology.
[84] F Meuwly,et al. Potential of cell retention techniques for large‐scale high‐density perfusion culture of suspended mammalian cells , 2003, Biotechnology and bioengineering.
[85] H. Aoyagi,et al. Changes in the quality of antibodies produced by Chinese hamster ovary cells during the death phase of cell culture. , 2010, Journal of bioscience and bioengineering.
[86] Lai-Xi Wang,et al. Chemoenzymatic synthesis and Fcγ receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcγIIIa receptor. , 2011, Journal of the American Chemical Society.
[87] M. Butler,et al. Comparisons of the Glycosylation of a Monoclonal Antibody Produced under Nominally Identical Cell Culture Conditions in Two Different Bioreactors , 2000, Biotechnology progress.
[88] André M Deelder,et al. Glycoproteomics based on tandem mass spectrometry of glycopeptides. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[89] Shigeru Iida,et al. Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity , 2004, Biotechnology and bioengineering.
[90] Barbara Imperiali,et al. Oligosaccharyl transferase: gatekeeper to the secretory pathway. , 2002, Current opinion in chemical biology.
[91] Maureen E. Taylor,et al. Introduction to glycobiology , 2003 .
[92] M. Takeuchi,et al. Remodeling of sugar chain structures of human interferon-gamma. , 2000, Glycobiology.
[93] G. Stiegler,et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. , 2008, Plant biotechnology journal.
[94] Z. Erbayraktar,et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[95] M. Butler,et al. Production and Glycosylation of Recombinant β‐Interferon in Suspension and Cytopore Microcarrier Cultures of CHO Cells , 2008, Biotechnology progress (Print).
[96] M. Lämmerhofer. Hydrophilic interaction chromatography. , 2008, Journal of separation science.
[97] R. Townsend,et al. Analysis of glycoprotein oligosaccharides using high-pH anion exchange chromatography. , 1991, Glycobiology.
[98] S. Kornfeld,et al. Glucose starvation alters lipid-linked oligosaccharide biosynthesis in Chinese hamster ovary cells. , 1981, The Journal of biological chemistry.
[99] M. Satoh,et al. Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC , 2008, Drug design, development and therapy.
[100] S. Harcum,et al. Temperature Effects on Product‐Quality‐Related Enzymes in Batch CHO Cell Cultures Producing Recombinant tPA , 2004, Biotechnology progress.
[101] Y. Jigami,et al. Production of humanized glycoproteins in bacteria and yeasts. , 2007, Current opinion in chemical biology.
[102] Tasneem H. Patwa,et al. Glycoprotein analysis using protein microarrays and mass spectrometry. , 2010, Mass spectrometry reviews.
[103] Kazuya Yamano,et al. Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA. , 2004, Biotechnology and bioengineering.
[104] T. Raju,et al. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. , 2008, Current opinion in immunology.
[105] Gregory Stephanopoulos,et al. Metabolic effects on recombinant interferon‐γ glycosylation in continuous culture of Chinese hamster ovary cells , 1999 .
[106] I. Wilson,et al. Insect cells as hosts for the expression of recombinant glycoproteins , 1999, Glycoconjugate Journal.
[107] James M. Lee,et al. Enhanced production of recombinant proteins from plant cells by the application of osmotic stress and protein stabilization , 2005, Plant Cell Reports.
[108] R B Freedman,et al. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. , 2001, Biotechnology and bioengineering.
[109] Ron A Wevers,et al. Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. , 2006, Clinical chemistry.
[110] U. Galili,et al. A unique natural human IgG antibody with anti-alpha-galactosyl specificity , 1984, The Journal of experimental medicine.
[111] C. Bertozzi,et al. Structural Basis of Glycan Diversity , 2009 .
[112] Lai-Xi Wang,et al. Emerging technologies for making glycan-defined glycoproteins. , 2012, ACS chemical biology.
[113] Renate Kunert,et al. Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo‐Fc expressing CHO cells cultivated in controlled batch bioreactors , 2006, Biotechnology and bioengineering.
[114] J. Cregg,et al. Heterologous protein expression in the methylotrophic yeast Pichia pastoris. , 2000, FEMS microbiology reviews.
[115] R. Dwek,et al. Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.
[116] R. Linhardt,et al. Enzyme kinetics and glycan structural characterization of secreted alkaline phosphatase prepared using the baculovirus expression vector system , 2002, Applied biochemistry and biotechnology.
[117] B. Scallon,et al. Fc Glycans Terminated with N‐Acetylglucosamine Residues Increase Antibody Resistance to Papain , 2007, Biotechnology progress.
[118] S. Elliott,et al. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. , 2005, Journal of pharmaceutical sciences.
[119] A. Bull,et al. Glucose‐limited chemostat culture of chinese hamster ovary cells producing recombinant human interferon‐γ , 1992, Biotechnology and bioengineering.
[120] Pauline M Rudd,et al. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. , 2006, Methods in molecular biology.
[121] D K Robinson,et al. Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.
[122] Å. Lundkvist,et al. Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus. , 1997, Virology.
[123] Lai-Xi Wang. Chemoenzymatic synthesis of glycopeptides and glycoproteins through endoglycosidase-catalyzed transglycosylation. , 2008, Carbohydrate research.
[124] Jinyou Zhang. Mammalian Cell Culture for Biopharmaceutical Production , 2010 .
[125] Renate Kunert,et al. Process parameter shifting: Part II. Biphasic cultivation—A tool for enhancing the volumetric productivity of batch processes using Epo‐Fc expressing CHO cells , 2006, Biotechnology and bioengineering.
[126] V. Gomord,et al. Posttranslational modification of therapeutic proteins in plants. , 2004, Current opinion in plant biology.
[127] Lai-Xi Wang,et al. Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation. , 2008, Biochemistry.
[128] Samuel Moser,et al. Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co‐expression of heterologous β1, 4‐N‐acetylglucosaminyltransferase III and Golgi α‐mannosidase II , 2006, Biotechnology and bioengineering.
[129] J. D. Yang,et al. Achievement of high cell density and high antibody productivity by a controlled-fed perfusion bioreactor process. , 2000, Biotechnology and bioengineering.
[130] Yoshiki Yamaguchi,et al. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. , 2007, Journal of molecular biology.
[131] Gary Walsh,et al. Post-translational modifications in the context of therapeutic proteins , 2006, Nature Biotechnology.
[132] A. Helenius,et al. Intracellular functions of N-linked glycans. , 2001, Science.
[133] Adrian Whitty,et al. Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β) , 1998, Pharmaceutical Research.
[134] B. Küster,et al. Glycosylation analysis of gel‐separated proteins , 2001, Proteomics.
[135] P. Roepstorff,et al. Biosynthesis and N-glycosylation of human interferon-gamma. Asn25 and Asn97 differ markedly in how efficiently they are glycosylated and in their oligosaccharide composition. , 1996, European journal of biochemistry.
[136] R. Dwek,et al. Recovery of intact 2-aminobenzamide-labeled O-glycans released from glycoproteins by hydrazinolysis. , 2002, Analytical biochemistry.
[137] D. Kompala,et al. Effect of Production Method and Gene Amplification on the Glycosylation Pattern of a Secreted Reporter Protein in CHO Cells , 2008, Biotechnology progress.
[138] Peiqing Zhang,et al. RCA-I-resistant CHO mutant cells have dysfunctional GnT I and expression of normal GnT I in these mutants enhances sialylation of recombinant erythropoietin. , 2010, Metabolic engineering.
[139] G. García-Casado,et al. Role of complex asparagine-linked glycans in the allergenicity of plant glycoproteins. , 1996, Glycobiology.
[140] A. Bull,et al. The macroheterogeneity of recombinant human interferon-gamma produced by Chinese-hamster ovary cells is affected by the protein and lipid content of the culture medium. , 1995, Biotechnology and applied biochemistry.
[141] W M Miller,et al. Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO(2) or pH. , 1999, Biotechnology and bioengineering.
[142] N. Raben,et al. Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice. , 2005, The Biochemical journal.
[143] R. Parekh,et al. Different culture methods lead to differences in glycosylation of a murine IgG monoclonal antibody. , 1992, The Biochemical journal.
[144] M. Martí-Renom,et al. N‐glycosylation efficiency is determined by the distance to the C‐terminus and the amino acid preceding an Asn‐Ser‐Thr sequon , 2011, Protein science : a publication of the Protein Society.
[145] Nigel Jenkins,et al. Effect of lipid supplements on the production and glycosylation of recombinant interferon-γ expressed in CHO cells , 2004, Cytotechnology.
[146] Pauline M. Rudd,et al. GlycoBase and autoGU: tools for HPLC-based glycan analysis , 2008, Bioinform..
[147] L. Taylor,et al. Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. , 1997, Analytical biochemistry.
[148] G. Stephanopoulos,et al. The effect of protein synthesis inhibitors on the glycosylation site occupancy of recombinant human prolactin , 2004, Cytotechnology.
[149] Louise Royle,et al. Separation‐based Glycoprofiling Approaches using Fluorescent Labels , 2007, Proteomics.
[150] J. Marth,et al. A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.
[151] U. Jacob,et al. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. , 2001, Journal of molecular biology.
[152] A. Varki,et al. Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. , 2008, Glycobiology.
[153] R. Jefferis,et al. Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action. , 2009, Trends in pharmacological sciences.
[154] J. Lofgren,et al. Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins , 1999, Nature Biotechnology.
[155] M. Aebi,et al. Transmembrane movement of dolichol linked carbohydrates during N-glycoprotein biosynthesis in the endoplasmic reticulum. , 2002, Seminars in cell & developmental biology.
[156] Akira Okazaki,et al. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. , 2007, Glycobiology.
[157] B. Shah,et al. Comparison of N‐Linked Oligosaccharides of Recombinant Human Tissue Kallikrein Produced by Chinese Hamster Ovary Cells on Microcarrier Beads and in Serum‐Free Suspension Culture , 1994, Biotechnology progress.
[158] P. Stahl,et al. Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver. , 1981, The Biochemical journal.
[159] Thomas Ryll,et al. Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment , 2010, Biotechnology progress.
[160] G. Lee,et al. Effect of sodium butyrate on the production, heterogeneity and biological activity of human thrombopoietin by recombinant Chinese hamster ovary cells. , 2004, Journal of biotechnology.
[161] T. Gerngross,et al. Glycosylation engineering in yeast: the advent of fully humanized yeast. , 2007, Current opinion in biotechnology.
[162] M. Butler,et al. Effect of Ammonia on the Glycosylation of Human Recombinant Erythropoietin in Culture , 2000, Biotechnology progress.
[163] W M Miller,et al. Glycosylation of CHO‐Derived Recombinant tPA Produced under Elevated pCO2 , 1997, Biotechnology progress.
[164] Guillermina Forno,et al. Temperature Reduction in Cultures of hGM‐CSF‐expressing CHO Cells: Effect on Productivity and Product Quality , 2008, Biotechnology progress.
[165] Pauline M Rudd,et al. A systematic approach to protein glycosylation analysis: a path through the maze. , 2010, Nature chemical biology.
[166] Y. Mechref,et al. Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis. , 2001, Analytical chemistry.
[167] L. Buck,et al. Enhancement of therapeutic protein in vivo activities through glycoengineering , 2003, Nature Biotechnology.
[168] O. Salas-Solano,et al. On-line CE-LIF-MS technology for the direct characterization of N-linked glycans from therapeutic antibodies. , 2008, Analytical chemistry.
[169] Michael Butler,et al. Expression systems for therapeutic glycoprotein production. , 2009, Current opinion in biotechnology.
[170] Frank Diederich,et al. Animal Cell Culture And Technology , 2016 .
[171] Johannes Kneer,et al. Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys. , 2007, Glycobiology.
[172] E. Heinzle,et al. Quantitative characterization of metabolism and metabolic shifts during growth of the new human cell line AGE1.HN using time resolved metabolic flux analysis , 2010, Bioprocess and biosystems engineering.
[173] Gregory Stephanopoulos,et al. Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells , 2000, IBM J. Res. Dev..
[174] R. Wait,et al. Relationships between the N‐glycan structures and biological activities of recombinant human erythropoietins produced using different culture conditions and purification procedures , 2003, British journal of haematology.
[175] W. Schumann,et al. Production of recombinant proteins in Escherichia coli , 2004 .
[176] R. Jefferis. Glycosylation of Recombinant Antibody Therapeutics , 2008, Biotechnology progress.
[177] T. Raju,et al. Glycosylation Variations with Expression Systems and Their Impact on Biological Activity of Therapeutic Immunoglobulins , 2003 .
[178] Gyun Min Lee,et al. Effect of culture pH on erythropoietin production by Chinese hamster ovary cells grown in suspension at 32.5 and 37.0 degrees C. , 2005, Biotechnology and bioengineering.
[179] S. Brooks. Appropriate glycosylation of recombinant proteins for human use , 2004, Molecular biotechnology.
[180] Pauline M Rudd,et al. An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. , 2002, Analytical biochemistry.
[181] H. Ohtake,et al. Decrease in antithrombin III fucosylation by expressing GDP-fucose transporter siRNA in Chinese hamster ovary cells. , 2008, Journal of bioscience and bioengineering.
[182] H. Desaire,et al. Glycopeptide analysis by mass spectrometry. , 2008, The Analyst.
[183] Teresa Mitchell,et al. Engineering of an artificial glycosylation pathway blocked in core oligosaccharide assembly in the yeast Pichia pastoris: production of complex humanized glycoproteins with terminal galactose. , 2004, Glycobiology.
[184] Andrew J Racher,et al. Antibody production. , 2006, Advanced drug delivery reviews.
[185] M. Mann,et al. Electrospray ionization for mass spectrometry of large biomolecules. , 1989, Science.
[186] P. Weigel,et al. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. , 2002, Biochimica et biophysica acta.
[187] J. Ravetch,et al. Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.
[188] B. van den Hazel,et al. Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. , 2003, The Journal of clinical endocrinology and metabolism.
[189] A. Dell,et al. Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. , 1987, The Journal of biological chemistry.
[190] M. Butler,et al. Effects of Ammonia and Glucosamine on the Heterogeneity of Erythropoietin Glycoforms , 2002, Biotechnology progress.
[191] P. Umaña,et al. The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms. , 2006, The Journal of biological chemistry.
[192] Katie F Wlaschin,et al. Recombinant protein therapeutics from CHO cells : 20 years and counting , 2007 .
[193] A. Bull,et al. Monitoring recombinant human interferon‐gamma N‐glycosylation during perfused fluidized‐bed and stirred‐tank batch culture of CHO cells , 1998, Biotechnology and bioengineering.
[194] N Jenkins,et al. Glycosylation of recombinant proteins: problems and prospects. , 1994, Enzyme and microbial technology.
[195] D. Reilly,et al. Production technologies for monoclonal antibodies and their fragments. , 2004, Current opinion in biotechnology.
[196] S. Brooks,et al. Strategies for Analysis of the Glycosylation of Proteins: Current Status and Future Perspectives , 2009, Molecular biotechnology.
[197] M. Butler,et al. Enhanced Production of Monomeric Interferon‐β by CHO Cells through the Control of Culture Conditions , 2008, Biotechnology progress.
[198] A K Patel,et al. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H. , 1995, Molecular immunology.
[199] Daniel C. Anthony,et al. Expanding the diversity of chemical protein modification allows post-translational mimicry , 2007, Nature.
[200] J. Vliegenthart,et al. Clonal analysis of the glycosylation of immunoglobulin G secreted by murine hybridomas. , 1989, Biochemistry.
[201] T. Arakawa,et al. The effect of carbohydrate on the structure and stability of erythropoietin. , 1991, The Journal of biological chemistry.
[202] Friedrich Altmann,et al. Peptide‐N4‐(N‐acetyl‐β‐glucosaminyl)asparagine amidase F cannot release glycans with fucose attached α1 → 3 to the asparagine‐linked N‐acetylglucosamine residue , 1991 .
[203] Gary Walsh,et al. Biopharmaceutical benchmarks 2010 , 2010, Nature Biotechnology.
[204] D. Jarvis,et al. Glycoproteins from Insect Cells: Sialylated or Not? , 2001, Biological chemistry.
[205] L. Monaco,et al. Na-butyrate increases the production and α2,6-sialylation of recombinant interferon-γ expressed by α2,6- sialyltransferase engineered CHO cells , 2004, Cytotechnology.
[206] Z. Li,et al. Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.
[207] R. Dwek,et al. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. , 1996, Analytical biochemistry.
[208] K. Fukuta,et al. Genetic engineering of CHO cells producing human interferon-γ by transfection of sialyltransferases , 2000, Glycoconjugate Journal.
[209] M. Dwek,et al. Breast Cancer Proteomics Using Two-Dimensional Electrophoresis , 2006 .
[210] M B Sliwkowski,et al. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. , 2000, Biotechnology and bioengineering.
[211] R. Horstkorte,et al. Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway. , 2009, Journal of pharmaceutical sciences.
[212] Huijuan Li,et al. Pharmacological significance of glycosylation in therapeutic proteins. , 2009, Current opinion in biotechnology.
[213] J. Davies,et al. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. , 2001, Biotechnology and bioengineering.
[214] S. Kamoda,et al. Capillary electrophoresis for the analysis of glycoprotein pharmaceuticals , 2006, Electrophoresis.
[215] Roy Jefferis,et al. Glycosylation as a strategy to improve antibody-based therapeutics , 2009, Nature Reviews Drug Discovery.
[216] Terrance A Stadheim,et al. Challenges in therapeutic glycoprotein production. , 2006, Current opinion in biotechnology.
[217] Rainer Fischer,et al. Plant cell cultures for the production of recombinant proteins , 2004, Nature Biotechnology.
[218] D. Macmillan,et al. Design and synthesis of a homogeneous erythropoietin analogue with two human complex-type sialyloligosaccharides: combined use of chemical and bacterial protein expression methods. , 2009, Angewandte Chemie.
[219] Y. Malykh,et al. Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy. , 2003, Biochimica et biophysica acta.
[220] Chi-Hsien Liu,et al. Rational development of serum-free medium for Chinese hamster ovary cells , 2006 .
[221] M. Betenbaugh,et al. Production and N-glycan analysis of secreted human erythropoietin glycoprotein in stably transfected Drosophila S2 cells. , 2005, Biotechnology and bioengineering.
[222] Yoshifumi Jigami,et al. Development of valuable yeast strains using a novel mutagenesis technique for the effective production of therapeutic glycoproteins. , 2008, Glycobiology.
[223] M. Mey,et al. Increasing Recombinant Protein Production in E. coli by an Alternative Method to Reduce Acetate , 2012 .
[224] Michael C. Borys,et al. Ammonia affects the glycosylation patterns of recombinant mouse placental lactogen‐I by chinese hamster ovary cells in a pH‐dependent manner , 1994, Biotechnology and bioengineering.
[225] J. Goergen,et al. Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells , 2007, Cytotechnology.
[226] A. Bull,et al. The effect of the dilution rate on CHO cell physiology and recombinant interferon‐γ production in glucose‐limited chemostat culture , 1993, Biotechnology and bioengineering.
[227] C. Goochee,et al. Glycosidase Activities in Chinese Hamster Ovary Cell Lysate and Cell Culture Supernatant , 1993, Biotechnology progress.
[228] R. Parekh,et al. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. , 1995, Analytical biochemistry.
[229] P. P. Gray,et al. Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells , 2004, Cytotechnology.
[230] Jianwei Zhu,et al. Mammalian cell protein expression for biopharmaceutical production. , 2012, Biotechnology advances.
[231] G. Gregoriadis,et al. The role of sialic acid in determining the survival of glycoproteins in the circulation. , 1971, The Journal of biological chemistry.
[232] J. Neefjes,et al. Protein glycosylation. , 1990, Current opinion in cell biology.
[233] T. Wurch,et al. Trends in glycosylation, glycoanalysis and glycoengineering of therapeutic antibodies and Fc-fusion proteins. , 2008, Current pharmaceutical biotechnology.
[234] C. Goochee,et al. The Oligosaccharides of Glycoproteins: Bioprocess Factors Affecting Oligosaccharide Structure and their Effect on Glycoprotein Properties , 1991, Bio/Technology.
[235] Y. Wada,et al. Diagnosis of carbohydrate-deficient glycoprotein syndrome by matrix-assisted laser desorption time-of-flight mass spectrometry. , 1994, Biological mass spectrometry.
[236] N. Packer,et al. Sequential analysis of N- and O-linked glycosylation of 2D-PAGE separated glycoproteins. , 2002, Journal of proteome research.
[237] G. Morgant,et al. A sensitive mapping strategy for monitoring the reproducibility of glycan processing in an HIV vaccine, RGP-160, expressed in a mammalian cell line , 2000, Glycoconjugate Journal.
[238] James E. Bailey,et al. Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity , 1999, Nature Biotechnology.
[239] Yehia Mechref,et al. High-throughput solid-phase permethylation of glycans prior to mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[240] Hong-Jin Kim,et al. Enhanced sialylation of recombinant erythropoietin in CHO cells by human glycosyltransferase expression. , 2008, Journal of microbiology and biotechnology.
[241] H. Gabius,et al. Eukaryotic glycosylation: whim of nature or multipurpose tool? , 1999, Cellular and Molecular Life Sciences CMLS.
[242] Scott Estes,et al. Development of a simple and rapid method for producing non‐fucosylated oligomannose containing antibodies with increased effector function , 2008, Biotechnology and bioengineering.
[243] S. Brooks,et al. SDS-PAGE and Western blotting to detect proteins and glycoproteins of interest in breast cancer research. , 2006, Methods in molecular medicine.
[244] C. Goochee,et al. Growth-associated glycosylation of transferrin secreted by HepG2 cells. , 1992, The Journal of biological chemistry.